An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
AngioDynamics to Present at the Needham Virtual Growth Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
AngioDynamics, Inc. (NASDAQ: ANGO), a leader in minimally invasive medical devices, announced that CEO Jim Clemmer and CFO Stephen Trowbridge will present at the 24th Annual Needham Virtual Growth Conference on January 10, 2022, at 2:00 p.m. ET. Investors can access a live webcast through the Company’s website, with a replay available afterward. AngioDynamics specializes in products for vascular access, peripheral vascular disease, and oncology, including market-leading ablation systems and vascular access products.
Positive
None.
Negative
None.
LATHAM, N.Y.--(BUSINESS WIRE)--
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 24th Annual Needham Virtual Growth Conference at 2:00 p.m. ET on Monday, January 10, 2022.
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products. For more information, visit www.angiodynamics.com.
AngioDynamics, Inc. Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
Source: AngioDynamics, Inc.
FAQ
What is AngioDynamics (ANGO) announcing for January 10, 2022?
AngioDynamics is announcing a presentation by CEO Jim Clemmer and CFO Stephen Trowbridge at the 24th Annual Needham Virtual Growth Conference on January 10, 2022.
At what time will AngioDynamics present at the Needham Conference?
AngioDynamics will present at 2:00 p.m. ET on January 10, 2022.
How can I watch the AngioDynamics presentation online?
The presentation can be accessed via a live webcast on AngioDynamics' website under the 'Investors' section.
What type of products does AngioDynamics (ANGO) provide?
AngioDynamics provides minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology.
Who are the leaders presenting for AngioDynamics at the conference?
The presentation will be made by CEO Jim Clemmer and CFO Stephen Trowbridge.
